Exhibitor

Since Icosagen’s establishment in 1999, we’ve applied our scientific background to tackle the shortcomings of existing technologies and have become one of the leading CRDMOs for the biopharmaceutical and biotech sectors. In 2023, we worked with 100+ companies. Our seamless services include early clinical candidate development and stable CHO cell line development for up to 1000L GMP productions. Clients trust us for custom-tailored solutions in every stage of drug development.